Skip to content
★ Sign in to follow
JM
Total declarations
97
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (48 ops.)
€1.8M

Latest filing published 01 Jun 2020 for Biolife Solutions INC, €1,842.

Filing timeline

BuySale
James Mathers

Insider track record

Disclosed buys
0
Disclosed sells
48
Signal history

James Mathers: trading record in brief

James Mathers discloses dealings in Biolife Solutions Inc to SEC (Form 4). The record holds 97 filings, for trades running from 1 January 2018 to 28 May 2020.

No open-market purchase appears, only 48 sales worth €1.8M. The rest of the record consists of 3 share grants and 46 option exercises. In 2020 alone, the filings show no purchases and 9 sales.

The record was last updated on 1 June 2020 with an open-market sale (€1,842) in Biolife Solutions Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to James Mathers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations97 total
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    2,041 USD29SEC
    121 shares@ US$16.870.2% of flowCommon StockSEC:0001437749-20-012244:0
  • ◆
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    0SEC
    3,101 sharesCommon StockSEC:0001437749-20-006394:0
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    7,630 USD29SEC
    508 shares@ US$15.020.4% of flowCommon StockSEC:0001437749-20-004027:0
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    29,645 USD29SEC
    2,113 shares@ US$14.031.4% of flowCommon StockSEC:0001437749-20-001950:1
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    3,465 USD11SEC
    2,113 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-001950:0
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-001098:0
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    39,225 USD26SEC
    2,500 shares@ US$15.691.8% of flowCommon StockSEC:0001437749-20-001098:1
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-001098:2
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    39,200 USD26SEC
    2,500 shares@ US$15.681.8% of flowCommon StockSEC:0001437749-20-001098:3
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-001098:4
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    37,775 USD26SEC
    2,500 shares@ US$15.111.7% of flowCommon StockSEC:0001437749-20-001098:5
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-000418:0
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    39,325 USD29SEC
    2,500 shares@ US$15.731.8% of flowCommon StockSEC:0001437749-20-000418:1
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-000418:2
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    40,125 USD29SEC
    2,500 shares@ US$16.051.8% of flowCommon StockSEC:0001437749-20-000418:3
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-20-000418:4
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    41,900 USD29SEC
    2,500 shares@ US$16.761.9% of flowCommon StockSEC:0001437749-20-000418:5
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-19-024973:0
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    41,000 USD29SEC
    2,500 shares@ US$16.401.9% of flowCommon StockSEC:0001437749-19-024973:1
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-19-024973:2
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    41,275 USD29SEC
    2,500 shares@ US$16.511.9% of flowCommon StockSEC:0001437749-19-024973:3
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-19-024973:4
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    41,525 USD29SEC
    2,500 shares@ US$16.611.9% of flowCommon StockSEC:0001437749-19-024973:5
  • ◇
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    4,100 USD11SEC
    2,500 shares@ US$1.640.2% of flowCommon StockSEC:0001437749-19-024354:0
  • ▼
    Chief Revenue OfficerExecutivesBiolife Solutions Inc
    39,125 USD29SEC
    2,500 shares@ US$15.651.8% of flowCommon StockSEC:0001437749-19-024354:1

25 of 97 declarations